JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 1.920
+0.040 (2.13%)
Mar 6, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 778.83 million as of March 6, 2026. Its market cap has increased by 19.53% in one year.
Market Cap
778.83M
Enterprise Value
477.95M
Revenue
194.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.92
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 778.83M, a decrease of -90.59%. That is a compound annual growth rate of -35.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 778.83M | -23.51% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.39B |
| HighTide Therapeutics | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.37B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| Wuhan YZY Biopharma | 1.10B |
| Transcenta Holding | 998.76M |
| Brii Biosciences | 995.72M |
| Sunho Biologics | 971.95M |